Product Name
Evaglip 25mg/5 mg
Features
Combination medication containing Empagliflozin 25 mg and Linagliptin 5 mg. Empagliflozin is an SGLT2 inhibitor, which helps lower blood sugar levels by promoting glucose excretion through urine. Linagliptin is a DPP-4 inhibitor, which helps increase insulin release and decrease the amount of sugar produced by the body. Used in the management of type 2 diabetes mellitus. May help in weight loss and reduce blood pressure as an added benefit.
Usage Instructions
Dosage: Typically, one tablet taken once daily, with or without food. Administration: Swallow the tablet whole with water. Missed Dose: Take the missed dose as soon as you remember. If it's almost time for the next dose, skip the missed dose. Do not double the dose to make up for the missed one. Storage: Store at room temperature away from moisture and heat.
Recommended Age/Weight Range
Age: Recommended for adults only. Weight: No specific weight range, but dosage may be adjusted based on individual response and tolerability under a healthcare provider's guidance.
Caution
Kidney Function: Regular monitoring of kidney function is advised, as the medication may affect renal performance. Liver Function: Periodic liver function tests may be necessary. Hypoglycemia: Risk of low blood sugar levels, especially when used with other diabetes medications. Dehydration: Increased urination can lead to dehydration; ensure adequate fluid intake. Urinary Tract Infections: Higher risk of UTIs; report symptoms to a healthcare provider. Ketoacidosis: Rare but serious condition; seek immediate medical attention if experiencing nausea, vomiting, stomach pain, or difficulty breathing. Pregnancy and Breastfeeding: Not recommended; consult a healthcare provider if pregnant or planning to become pregnant. Medication Interactions: Inform your healthcare provider of all medications you are taking to avoid potential interactions.
0 Review For Evaglip Tablet